Related Experiment Video
Updated: Feb 17, 2026

Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models
Published on: October 3, 2019
Genome Editing: The Recent History and Perspective in Cardiovascular Diseases
1Cardiovascular Institute, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania; and the Department of Genetics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
Abstract:
The genome-editing field has advanced to a remarkable degree in the last 5 years, culminating in the successful correction of a cardiomyopathy gene mutation in viable human embryos. In this review, the author discusses the basic principles of genome editing, recent advances in clustered regularly interspaced short palindromic repeats and clustered regularly interspaced short palindromic repeats-associated 9 technology, the impact on cardiovascular basic science research, possible therapeutic applications in patients with cardiovascular diseases, and finally the implications of potential clinical uses of human germline genome editing.
Related Concept Videos
CRISPR
What is Genetic Engineering?
Pharmacogenomics: Identification of New Drug Targets
Animal Mitochondrial Genetics
CRISPR/Cas9 Genome Editing
Pharmacogenetics and Pharmacogenomics: Overview

